NeuroPace(NPCE) - 2024 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2025 NEUROPACE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40337 22-3550230 (State or Other Jurisdiction of Incorporation) 455 N. Bernardo Avenue Mountain View, CA 94043 (Address of principal executive offices) (Zip Code) (Commission File Number) (IRS Em ...